Pharmacological targeting of the protein synthesis mTOR/4E‐BP1 pathway in cancer‐associated fibroblasts abrogates pancreatic tumour chemoresistanceCamille Duluc, Corinne Bousquet, Siham Moatassim-Billah et al.|EMBO Molecular Medicine|2015Cited by 196
FAK activity in cancer‐associated fibroblasts is a prognostic marker and a druggable key metastatic player in pancreatic cancerSonia Zaghdoudi, Christine Jean, Stéphane Pyronnet et al.|EMBO Molecular Medicine|2020Cited by 105
Periostin‐ and podoplanin‐positive cancer‐associated fibroblast subtypes cooperate to shape the inflamed tumor microenvironment in aggressive pancreatic adenocarcinomaCindy Neuzillet, Corinne Bousquet, Rémy Nicolle et al.|The Journal of Pathology|2022Cited by 66
Anti-metastatic potential of somatostatin analog SOM230: Indirect pharmacological targeting of pancreatic cancer-associated fibroblastsSiham Moatassim-Billah, Corinne Bousquet, Camille Duluc et al.|Oncotarget|2016Cited by 39
Pharmacologic Normalization of Pancreatic Cancer-Associated Fibroblast Secretome Impairs Prometastatic Cross-Talk With MacrophagesRémi Samain, Corinne Bousquet, Alexia Brunel et al.|Cellular and Molecular Gastroenterology and Hepatology|2021Cited by 32